Active infection requiring parenteral or oral antibiotics within 2 weeks before planned start of study therapy
Known active infection requiring parenteral or oral anti-infective treatment within 14 days of randomization.
Current infection requiring parenteral antibiotics
Known active infection requiring parenteral or oral anti-infective treatment, once a patient has completed antibiotics and symptoms of infection have resolved to < grade 2, they are then considered eligible from an infection standpoint
Active infection requiring parenteral antibiotics within 2 weeks before planned first dose of study drug
Serious/active infection or infection requiring parenteral antibiotics
Current infection requiring parenteral antibiotics
Known active infection requiring parenteral or oral anti-infective treatment within 14 days of initiation of therapy
Current infection requiring parenteral antibiotics
Have uncontrolled intercurrent illness including, but not limited to, an ongoing/active infection requiring parenteral antibiotics.
Known active infection requiring parenteral anti-infective treatment at the time of initiation of treatment
Active infection requiring parenteral antibiotics
Serious/active infection or infection requiring parenteral antibiotics
Patients with acute hepatitis or active infection that requires parenteral antibiotics
Active infection requiring parenteral antibiotics
Subjects with active infection that requires parenteral antibiotics
Active infection requiring parenteral antibiotics
Active infection requiring parenteral antibiotics
Major active infection requiring parenteral antibiotics.
Active infection requiring parenteral antibiotics
Active infection requiring parenteral antibiotics.
Patients must not have an active infection requiring current treatment with parenteral antibiotics
Patients with acute hepatitis or active infection that requires parenteral antibiotics
Patients should be free of active infection requiring parenteral antibiotics.
Patients with active infection requiring parenteral antibiotics.
Known active infection requiring parenteral or oral anti-infective treatment
Ongoing infection that requires parenteral treatment with antibiotics
Current infection requiring parenteral antibiotics
Patients should be free of active infection requiring parenteral antibiotics or a serious uncontrolled medical illness or disorder within four weeks of study entry.
Subjects with active infection that requires parenteral antibiotics
Uncontrolled intercurrent illness including, but not limited to, ongoing or active infection requiring parenteral antibiotics on day 1
Known active infection requiring parenteral or oral anti-infective treatment
Serious/active infection or infection requiring parenteral antibiotics
Patients with acute hepatitis or active infection that requires parenteral antibiotics are excluded
Uncontrolled intercurrent illness including, but not limited to, ongoing or active infection requiring parenteral antibiotics on day 1
Patients with acute hepatitis or active infection that requires parenteral antibiotics.
Patients must not have a serious intercurrent illness including, but not limited to, ongoing or active infection requiring parenteral antibiotics
Known active infection requiring parenteral or oral anti-infective treatment.
Ongoing or active infection requiring parenteral antibiotics.
Serious/active infection or infection requiring parenteral antibiotics
Active infection requiring parenteral antibiotics
The patient has ongoing or active infection requiring parenteral antibiotics.
Patients with any other serious/active/uncontrolled infection, any infection requiring parenteral antibiotics, or unexplained fever > 38ºC within 1 week prior to first study drug administration.
Serious infection requiring parenteral antibiotics within 14 days of enrollment
Patients with any other serious/active/uncontrolled infection, any infection requiring parenteral antibiotics, or unexplained fever > 38ºC within 2 weeks prior to first study drug administration.
Serious/active infection or infection requiring parenteral antibiotics
Active infection requiring parenteral antibiotics within one-week prior to study
Active infection requiring parenteral antibiotics
Have had an infection requiring the use of parenteral antibiotics within 14 days prior to the start of Day 1;
Any infection requiring parenteral antibiotics within the past 2 weeks
No active infection within 14 days of study enrollment requiring parenteral antibiotics
Known active infection requiring parenteral or oral anti-infective treatment within defined period
Current infection requiring parenteral antibiotics
